Ambrx
Jakob Dupont, M.D., is a renowned expert in oncology, immunology, and cell therapy with vast experience in developing therapies and programs, especially for breast and gynecological cancers. Dr. Dupont is the Global Head of Research & Development and EVP at Atara Biotherapeutics and is a Director at Apexigen. Prior to Atara, Dr. Dupont served as Chief Medical Officer at Gossamer Bio. Prior to Gossamer, Dr. Dupont served as Global Head of Breast and Gynecologic Cancer Development and VP for Genentech/Roche. Dr. Dupont received his M.D. from the Joan & Sanford I. Weill Medical College of Cornell University and his M.A. in philosophy from New York University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Ambrx
Ambrx, Inc. is a biopharmaceutical company with a mission to deliver breakthrough protein therapeutics. Ambrx is based on a fundamental advance in protein biosynthesis that enables the company to genetically engineer proteins with new amino acid building blocks beyond the common twenty, enabling the biosynthesis of proteins with new physical, chemical and pharmacological properties.